Literature DB >> 26464708

Expression of claudin-5, -7, -8 and -9 in cervical carcinoma tissues and adjacent non-neoplastic tissues.

Jianyou Zhu1, Rugang Wang2, Hongyun Cao2, Haipeng Zhang1, Shaoyan Xu1, Aiyun Wang1, Bin Liu1, Yongtao Wang1, Ruicai Wang1.   

Abstract

Recent data indicate that the tight junction proteins are abnormally regulated in several human cancers and the expression of these proteins is involved in the etiology and progression of cancer. To explore the expression distinction of the tight junction proteins claudin-5, -7, -8 and -9 in the adjacent non-neoplastic tissues and cervical carcinoma tissues, 72 cervical carcinoma tissues and the samples of non-neoplastic tissues adjacent to the tumors were examined for expression of claudin-5, -7, -8 and -9 by streptavidin-perosidase immunohistochemical staining method. The positive expression rates of claudin-5 in cervical carcinoma tissues and adjacent non-neoplastic tissues were 31.9% (23/72) and 51.4% (37/72) respectively (P < 0.05). The positive expression rates of claudin-7 in cervical carcinoma tissues and adjacent non-neoplastic tissues were 47.2% and 50.0% respectively (P = 1.000). The positive expression rates of claudin-8 in cervical carcinoma tissues and adjacent non-neoplastic tissues were 54.2 % and 27.8% respectively (P < 0.01). The positive expression rates of claudin-9 in cervical carcinoma tissues and adjacent non-neoplastic tissues were 38.9% and 56.9% respectively (P < 0.05). Thus in our study, the expression of claudin-5 and claudin-9 was down-regulated while the expression of claudin-8 was up-regulated in cervical carcinoma tissues compared with adjacent non-neoplastic tissues. The expression of claudin-7 has no obviously difference between cervical carcinoma tissues and adjacent non-neoplastic tissues. In addition, correlations between claudin-5, -8 and -9 expression with lymphatic metastasis were observed. Our study reveals that the expression of claudin-5, -8 and -9 altered between in cervical carcinoma tissues and adjacent non-neoplastic tissues.

Entities:  

Keywords:  Tight junction; cervical carcinoma; claudin-5; claudin-7; claudin-8; claudin-9

Mesh:

Substances:

Year:  2015        PMID: 26464708      PMCID: PMC4583940     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  47 in total

Review 1.  Tight junction proteins.

Authors:  L González-Mariscal; A Betanzos; P Nava; B E Jaramillo
Journal:  Prog Biophys Mol Biol       Date:  2003-01       Impact factor: 3.667

Review 2.  Tight junctions/adherens junctions: basic structure and function.

Authors:  Carien M Niessen
Journal:  J Invest Dermatol       Date:  2007-11       Impact factor: 8.551

Review 3.  Loss of tight junction barrier function and its role in cancer metastasis.

Authors:  Tracey A Martin; Wen G Jiang
Journal:  Biochim Biophys Acta       Date:  2008-11-14

4.  The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton.

Authors:  A S Fanning; B J Jameson; L A Jesaitis; J M Anderson
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

5.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

6.  Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer.

Authors:  F Krämer; K White; M Kubbies; K Swisshelm; B H Weber
Journal:  Hum Genet       Date:  2000-09       Impact factor: 4.132

7.  Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer.

Authors:  Tracey A Martin; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Eur J Cancer       Date:  2004-12       Impact factor: 9.162

8.  Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity.

Authors:  K B Hoover; S Y Liao; P J Bryant
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells.

Authors:  T Yamamoto; N Harada; K Kano; S Taya; E Canaani; Y Matsuura; A Mizoguchi; C Ide; K Kaibuchi
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

10.  The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density.

Authors:  Maria S Balda; Michelle D Garrett; Karl Matter
Journal:  J Cell Biol       Date:  2003-02-03       Impact factor: 10.539

View more
  7 in total

1.  A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis.

Authors:  Rajesh K Sharma; Zinal S Chheda; Biswa Pratim Das Purkayastha; Jorge G Gomez-Gutierrez; Venkatakrishna R Jala; Bodduluri Haribabu
Journal:  Clin Exp Metastasis       Date:  2015-12-15       Impact factor: 5.150

Review 2.  Candidate biomarkers in the cervical vaginal fluid for the (self-)diagnosis of cervical precancer.

Authors:  Xaveer Van Ostade; Martin Dom; Wiebren Tjalma; Geert Van Raemdonck
Journal:  Arch Gynecol Obstet       Date:  2017-11-15       Impact factor: 2.344

3.  Differences in the expression profiles of claudin proteins in human nasopharyngeal carcinoma compared with non-neoplastic mucosa.

Authors:  Xiaowei Zhang; Haiming Wang; Qian Li; Yunpeng Liu; Peiqing Zhao; Tao Li
Journal:  Diagn Pathol       Date:  2018-02-05       Impact factor: 2.644

4.  Non-tight junction-related function of claudin-7 in interacting with integrinβ1 to suppress colorectal cancer cell proliferation and migration.

Authors:  Wenjing Li; Chang Xu; Kun Wang; Yuhan Ding; Lei Ding
Journal:  Cancer Manag Res       Date:  2019-02-13       Impact factor: 3.989

Review 5.  Mouse Models of Human Claudin-Associated Disorders: Benefits and Limitations.

Authors:  Murat Seker; Carmen Fernandez-Rodriguez; Luis Alfonso Martinez-Cruz; Dominik Müller
Journal:  Int J Mol Sci       Date:  2019-11-05       Impact factor: 5.923

6.  Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.

Authors:  Linqi Yang; Wenqi Zhang; Meng Li; Jinxi Dam; Kai Huang; Yihan Wang; Zhicong Qiu; Tao Sun; Pingping Chen; Zhenduo Zhang; Wei Zhang
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

7.  Differences in the expression profiles of claudin proteins in human gastric carcinoma compared with non‑neoplastic mucosa.

Authors:  Luoluo Yang; Xun Sun; Xiangwei Meng
Journal:  Mol Med Rep       Date:  2018-06-01       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.